EPIPROGOITRIN

EPIPROGOITRIN Struktur
19237-18-4
CAS-Nr.
19237-18-4
Englisch Name:
EPIPROGOITRIN
Synonyma:
EPIPROGOITRIN;epi-progoitrin(1-);β-D-Glucopyranose, 1-thio-, 1-[(3S)-3-hydroxy-N-(sulfooxy)-4-pentenimidate];1-Thio-β-D-glucopyranose 1-[(S)-N-(hydroxysulfonyloxy)-3-hydroxy-4-penteneimidate]
CBNumber:
CB41417339
Summenformel:
C11H19NO10S2
Molgewicht:
389.4
MOL-Datei:
19237-18-4.mol

EPIPROGOITRIN Eigenschaften

Sicherheit

EPIPROGOITRIN Chemische Eigenschaften,Einsatz,Produktion Methoden

Definition

ChEBI: The stereoisomer of xi-progoitrin that has S at the carbon bearing the allylic hydroxy group.

EPIPROGOITRIN Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


EPIPROGOITRIN Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 14)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354;
support@targetmol.com United States 39035 58
ShangHai YuanYe Biotechnology Co., Ltd. 021-61312847 13636370518
shyysw007@163.com China 4999 60
Shanghai Winherb Medical Technology Co., Ltd. 021-38218169 13341702378
winherb@126.com China 1245 58
Beijing OKA biological technology co., LTD 010-62971590 18548936886
3462612863@qq.com China 10063 58
cjbscvictory 13348960310
3003867561@qq.com China 10505 58
TCI (Shanghai) Chemical Trading Co., Ltd. 021-61109150
sales@tcisct.com China 29668 58
Shanghai Moqi Biological Technology Co., LTD 021-38218169 13681877033
2702713455@qq.com China 9997 58
Wuhan Huangzhen Biochemical Co., Ltd 13795480948
3450865996@qq.com China 4958 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780
sales@biosynth.com China 6051 58
Guangzhou Bingheng Biotechnology Co., Ltd. 13631342304
CHINA 188 58

19237-18-4()Verwandte Suche:


  • EPIPROGOITRIN
  • 1-Thio-β-D-glucopyranose 1-[(S)-N-(hydroxysulfonyloxy)-3-hydroxy-4-penteneimidate]
  • epi-progoitrin(1-)
  • β-D-Glucopyranose, 1-thio-, 1-[(3S)-3-hydroxy-N-(sulfooxy)-4-pentenimidate]
  • 19237-18-4
  • C11H18NO9S2
Copyright 2019 © ChemicalBook. All rights reserved